A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Paroxysmal Nocturnal Hemoglobinuria

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Hospital das Clinicas da FMRP USP, Ribeirão Preto, São Paulo, Brazil

  • Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil

  • CISSS-CA, Lévis, Quebec, Canada

  • Universita Cattolica del Sacro Cuore - Policlinico Universitario A. Gemelli, Rome, Lazio, Italy

  • AOU Careggi, Florence, Tuscany, Italy

  • SC Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy

  • In-Vivo Sp. z o.o., Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland

  • Seoul National University Hospital, Seoul, South Korea

  • Severance Hospital, Seoul, South Korea

  • Seoul St. Mary's Hospital - The Catholic University of Korea, Seoul, South Korea

  • Ewha Womans University Mokdong Hospital, Seoul, South Korea

  • Samsung Medical Center, Seoul, South Korea

  • Hospital Universitario Basurto, Bilbao, Vizcaya, Spain

  • Institut Catala d'Oncologia, Barcelona, Spain

  • Hospital San Pedro de Alcantara, Cáceres, Spain

  • Hospital General JM Morales Meseguer, Murcia, Spain

  • Hospital Universitario de Salamanca, Salamanca, Spain

  • Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey (Türkiye)

  • Ege University, Izmir, Turkey (Türkiye)

מובילי המחקר
  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals